We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > BENDEKA

News List

Teva moves US court against Aurobindo Pharma on cancer drug Bendeka expresspharma
May 15, 2020
A probable patent infringement petition against Aurobindo in the US district court for the District of Delaware on 28 counts.
Eagle Pharmaceuticals Announces New Patent for Bendeka americanpharmaceuticalreview
August 23, 2018
Eagle Pharmaceuticals announced that an additional patent has been issued related to Bendeka by the United States Patent and Trademark Office (USPTO). Patent number 10,052,385 will expire March 2033. The USPTO has now issued or allowed a total of 16 paten
Eagle Pharmaceuticals Announces New Patent Issued for Bendeka americanpharmaceuticalreview
July 11, 2018
Eagle Pharmaceuticals announced that an additional patent has been issued related to Bendeka by the United States Patent and Trademark Office (USPTO).